Skip to main content
Figure 1 | Molecular Cancer

Figure 1

From: Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

Figure 1

ErbB2-positive human breast tumors express cannabinoid receptors. (A) Representative images of human breast tumors negative (upper row) or positive (lower row) for CB1, CB2 and ErbB2 receptors (brown). Scale bars: 200 μm; insets: 100 μm. (B) Percentage of tumors scored as positive or negative for cannabinoid receptor expression amongst the ErbB2-negative (n = 64) and ErbB2-positive (n = 23) populations.

Back to article page